Copyright Reports & Markets. All rights reserved.

Oncolytic Virus Therapy-Global Market Status and Trend Report 2016-2026

Request for Sample of this report
Buy now

Table of Contents

    Chapter 1 Overview of Oncolytic Virus Therapy

    • 1.1 Definition of Oncolytic Virus Therapy in This Report
    • 1.2 Commercial Types of Oncolytic Virus Therapy
      • 1.2.1 HSV-based Oncolytic Viruses
      • 1.2.2 Adenoviruses-based Oncolytic Viruses
      • 1.2.3 Vaccinia Virus-based Oncolytic Viruses
      • 1.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
      • 1.2.5 Newcastle Disease Virus-based Oncolytic Viruses
    • 1.3 Downstream Application of Oncolytic Virus Therapy
      • 1.3.1 Melanoma
      • 1.3.2 Prostate Cancer
      • 1.3.3 Breast Cancer
      • 1.3.4 Ovarian Cancer
      • 1.3.5 Others
    • 1.4 Development History of Oncolytic Virus Therapy
    • 1.5 Market Status and Trend of Oncolytic Virus Therapy 2016-2026
      • 1.5.1 Global Oncolytic Virus Therapy Market Status and Trend 2016-2026
      • 1.5.2 Regional Oncolytic Virus Therapy Market Status and Trend 2016-2026

    Chapter 2 Global Market Status and Forecast by Regions

    • 2.1 Market Development of Oncolytic Virus Therapy 2016-2021
    • 2.2 Production Market of Oncolytic Virus Therapy by Regions
      • 2.2.1 Production Volume of Oncolytic Virus Therapy by Regions
      • 2.2.2 Production Value of Oncolytic Virus Therapy by Regions
    • 2.3 Demand Market of Oncolytic Virus Therapy by Regions
    • 2.4 Production and Demand Status of Oncolytic Virus Therapy by Regions
      • 2.4.1 Production and Demand Status of Oncolytic Virus Therapy by Regions 2016-2021
      • 2.4.2 Import and Export Status of Oncolytic Virus Therapy by Regions 2016-2021

    Chapter 3 Global Market Status and Forecast by Types

    • 3.1 Production Volume of Oncolytic Virus Therapy by Types
    • 3.2 Production Value of Oncolytic Virus Therapy by Types
    • 3.3 Market Forecast of Oncolytic Virus Therapy by Types

    Chapter 4 Global Market Status and Forecast by Downstream Industry

    • 4.1 Demand Volume of Oncolytic Virus Therapy by Downstream Industry
    • 4.2 Market Forecast of Oncolytic Virus Therapy by Downstream Industry

    Chapter 5 Market Driving Factor Analysis of Oncolytic Virus Therapy

    • 5.1 Global Economy Situation and Trend Overview
    • 5.2 Oncolytic Virus Therapy Downstream Industry Situation and Trend Overview

    Chapter 6 Oncolytic Virus Therapy Market Competition Status by Major Manufacturers

    • 6.1 Production Volume of Oncolytic Virus Therapy by Major Manufacturers
    • 6.2 Production Value of Oncolytic Virus Therapy by Major Manufacturers
    • 6.3 Basic Information of Oncolytic Virus Therapy by Major Manufacturers
      • 6.3.1 Headquarters Location and Established Time of Oncolytic Virus Therapy Major Manufacturer
      • 6.3.2 Employees and Revenue Level of Oncolytic Virus Therapy Major Manufacturer
    • 6.4 Market Competition News and Trend
      • 6.4.1 Merger, Consolidation or Acquisition News
      • 6.4.2 Investment or Disinvestment News
      • 6.4.3 New Product Development and Launch

    Chapter 7 Oncolytic Virus Therapy Major Manufacturers Introduction and Market Data

    • 7.1 Amgen
      • 7.1.1 Company profile
      • 7.1.2 Representative Oncolytic Virus Therapy Product
      • 7.1.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Amgen
    • 7.2 Oncolytics Biotech
      • 7.2.1 Company profile
      • 7.2.2 Representative Oncolytic Virus Therapy Product
      • 7.2.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Oncolytics Biotech
    • 7.3 Viralytics
      • 7.3.1 Company profile
      • 7.3.2 Representative Oncolytic Virus Therapy Product
      • 7.3.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Viralytics
    • 7.4 Transgene SA
      • 7.4.1 Company profile
      • 7.4.2 Representative Oncolytic Virus Therapy Product
      • 7.4.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Transgene SA
    • 7.5 Oncolys BioPharma
      • 7.5.1 Company profile
      • 7.5.2 Representative Oncolytic Virus Therapy Product
      • 7.5.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Oncolys BioPharma
    • 7.6 Targovax
      • 7.6.1 Company profile
      • 7.6.2 Representative Oncolytic Virus Therapy Product
      • 7.6.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Targovax
    • 7.7 PsiOxus Therapeutics
      • 7.7.1 Company profile
      • 7.7.2 Representative Oncolytic Virus Therapy Product
      • 7.7.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of PsiOxus Therapeutics
    • 7.8 SillaJen Biotherapeutics
      • 7.8.1 Company profile
      • 7.8.2 Representative Oncolytic Virus Therapy Product
      • 7.8.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of SillaJen Biotherapeutics
    • 7.9 Sorrento Therapeutics
      • 7.9.1 Company profile
      • 7.9.2 Representative Oncolytic Virus Therapy Product
      • 7.9.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Sorrento Therapeutics
    • 7.10 Lokon Pharma
      • 7.10.1 Company profile
      • 7.10.2 Representative Oncolytic Virus Therapy Product
      • 7.10.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Lokon Pharma
    • 7.11 Genelux Corporation
      • 7.11.1 Company profile
      • 7.11.2 Representative Oncolytic Virus Therapy Product
      • 7.11.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Genelux Corporation
    • 7.12 Vyriad
      • 7.12.1 Company profile
      • 7.12.2 Representative Oncolytic Virus Therapy Product
      • 7.12.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Vyriad
    • 7.13 TILT Biotherapeutics
      • 7.13.1 Company profile
      • 7.13.2 Representative Oncolytic Virus Therapy Product
      • 7.13.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of TILT Biotherapeutics
    • 7.14 Cold Genesys
      • 7.14.1 Company profile
      • 7.14.2 Representative Oncolytic Virus Therapy Product
      • 7.14.3 Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin of Cold Genesys

    Chapter 8 Upstream and Downstream Market Analysis of Oncolytic Virus Therapy

    • 8.1 Industry Chain of Oncolytic Virus Therapy
    • 8.2 Upstream Market and Representative Companies Analysis
    • 8.3 Downstream Market and Representative Companies Analysis

    Chapter 9 Cost and Gross Margin Analysis of Oncolytic Virus Therapy

    • 9.1 Cost Structure Analysis of Oncolytic Virus Therapy
    • 9.2 Raw Materials Cost Analysis of Oncolytic Virus Therapy
    • 9.3 Labor Cost Analysis of Oncolytic Virus Therapy
    • 9.4 Manufacturing Expenses Analysis of Oncolytic Virus Therapy

    Chapter 10 Marketing Status Analysis of Oncolytic Virus Therapy

    • 10.1 Marketing Channel
      • 10.1.1 Direct Marketing
      • 10.1.2 Indirect Marketing
      • 10.1.3 Marketing Channel Development Trend
    • 10.2 Market Positioning
      • 10.2.1 Pricing Strategy
      • 10.2.2 Brand Strategy
      • 10.2.3 Target Client
    • 10.3 Distributors/Traders List

    Chapter 11 Report Conclusion

      Chapter 12 Research Methodology and Reference

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources

      Report Summary

      Oncolytic Virus Therapy-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Oncolytic Virus Therapy industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

      Worldwide and Regional Market Size of Oncolytic Virus Therapy 2016-2021, and development forecast 2022-2026
      Main manufacturers/suppliers of Oncolytic Virus Therapy worldwide, with company and product introduction, position in the Oncolytic Virus Therapy market
      Market status and development trend of Oncolytic Virus Therapy by types and applications
      Cost and profit status of Oncolytic Virus Therapy, and marketing status
      Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Oncolytic Virus Therapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Oncolytic Virus Therapy industry.

      The report segments the global Oncolytic Virus Therapy market as:

      Global Oncolytic Virus Therapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
      North America
      Europe
      China
      Japan
      Rest APAC
      Latin America

      Global Oncolytic Virus Therapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
      HSV-based Oncolytic Viruses
      Adenoviruses-based Oncolytic Viruses
      Vaccinia Virus-based Oncolytic Viruses
      Vesicular Stomatitis Virus-based Oncolytic Viruses
      Newcastle Disease Virus-based Oncolytic Viruses

      Global Oncolytic Virus Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
      Melanoma
      Prostate Cancer
      Breast Cancer
      Ovarian Cancer
      Others

      Global Oncolytic Virus Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Oncolytic Virus Therapy Sales Volume, Revenue, Price and Gross Margin):
      Amgen
      Oncolytics Biotech
      Viralytics
      Transgene SA
      Oncolys BioPharma
      Targovax
      PsiOxus Therapeutics
      SillaJen Biotherapeutics
      Sorrento Therapeutics
      Lokon Pharma
      Genelux Corporation
      Vyriad
      TILT Biotherapeutics
      Cold Genesys

      In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
      Buy now